#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Peritoneal neoplasm Hypereosinophilic syndrome Myelodysplastic syndrome Langerhans' cell histiocytosis Pleural mesothelioma malignant Squamous cell carcinoma of head and neck Cutaneous T-cell lymphoma refractory Squamous cell carcinoma of the cervix Prolymphocytic leukaemia Bone marrow disorder Gastroenteropancreatic neuroendocrine tumour disease Wiskott-Aldrich syndrome Hepatitis D Ocular myasthenia Multiple system atrophy More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Life with Disease Burkitt’s lymphoma – Treatment Adrenogenital syndrome – Diagnostics Antisynthetase syndrome – Basic Information Prolymphocytic leukaemia Myxofibrosarcoma – Treatment Focal segmental glomerulosclerosis – Life with Disease Ornithine transcarbamoylase deficiency – Life with Disease Mast cell activation syndrome – Diagnostics Leukoencephalopathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    2,4 DICHLOROBENZYL ALCOHOL Nacystelyn Mifepristone Dacarbazine Citrate Gilteritinib ALE1 Pazopanib Vortioxetine OMECAMTIV MECARBIL Fianlimab Nms-03305293 GEN1078 Cefazolin Sodium For-6219 Ficlatuzumab Treprostinil Sodium Skin Autograft Vepdegestrant Ceftazidime Pentahydrate Alendronate Sodium Monohydrate More therapies…

    Learn about Your Condition

    Vesicoureteric reflux Hyperphagia Stargardt's disease Alcoholic liver disease T-cell type acute leukaemia Mite allergy Hysterectomy Psychological trauma Endometrial cancer stage IV Spondylolisthesis Primary adrenal insufficiency Angiosarcoma recurrent Post procedural hypotension Adenocarcinoma of colon Non-Hodgkin's lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal failure

  • Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Amoxicillin
    • Clindamycin
    • Clavulanic Acid
    Denmark

  • Study on Everolimus for Preventing Rejection in Adult Kidney Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Everolimus
    France

  • Study on Optimal Dose of Rabbit Anti-Human T-Lymphocyte Immunoglobulin and Mycophenolic Acid for Kidney Transplant Patients with Low Immunological Risk

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Mycophenolic Acid
    France

  • Study to Compare Non-Radioactive Methods for Measuring Kidney Function in Patients with Chronic Kidney Disease Using Sodium Iotalamate, Sodium Iodohippurate, and Iohexol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Iotalamate (125I)
    • Clemastine
    • Iohexol
    The Netherlands

  • Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Haemodialysis
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Austria

  • Study on Reducing Tacrolimus Dose in Kidney Transplant Patients Using LCPT Compared to Tacrolimus-ER

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!